Table 3.
Variables | Treatment Delay | Adjusted Odds Ratio (95% CI) | P-value | |
---|---|---|---|---|
Yes | No | |||
Sex of patient | ||||
Male | 144 | 122 | 1 | |
Female | 96 | 94 | 0.76 (0.49 1.19) | 0.48 |
Residence | ||||
Urban | 114 | 104 | 1 | |
Rural | 126 | 112 | 0.98 (0.63 1.50) | 0.98 |
Age group | ||||
<24 | 81 | 72 | 1 | |
25–34 | 70 | 72 | 0.78 (0.46 1.31) | 0.31 |
35–44 | 49 | 38 | 1.17 (0.62 2.18) | 0.66 |
>45 | 40 | 34 | 1.05 (0.55 1.99) | 0.89 |
Functional status | ||||
Working | 34 | 28 | 1 | |
Bedridden | 206 | 188 | 0.69 (0.37 1.30) | 0.25 |
Has treatment supporter | ||||
Yes | 201 | 187 | 1 | |
No | 39 | 29 | 1.67 (0.91 3.05) | 0.17 |
Complications | ||||
Yes | 101 | 94 | 1 | |
No | 130 | 122 | 1.0 (0.65 1.54) | 0.97 |
TB/HIV-co-infection | ||||
Yes | 54 | 64 | 0.68 (0.41 1.13) | 0.12 |
No | 186 | 152 | 1 | |
Cavitation | ||||
Yes | 99 | 141 | 0.62 (0.39 0.96)* | 0.028 |
No | 91 | 125 | 1 | |
GeneXpert MTB/RIF test | ||||
Yes | 66 | 146 | 0.15 (0.10 0.24)* | <0.001 |
No | 174 | 70 | 1 | |
Form of TB | ||||
Pulmonary | 288 | 193 | 1 | |
Extrapulmonary | 12 | 23 | 0.34 (0.14 0.81)* | 0.018 |
Note: *Shows statistical significant at 0.05 P-value in the multivariable logistic regression model.